Early recurrence factors in patients with stage Ⅲ non-small cell lung cancer treated with concurrent chemoradiotherapy, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno, Thorac Cancer, 13:3451-3458, Dec. 2022
Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case series, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno, Cancer Reports(Hoboken,NJ), e1754:1-8, Nov. 2022
Lung cancer with post-fracture healing changes causing difficulty in staging, Yutaka Takahara, Ikuyo Shionoya, Akihiro Shioya, Shohei Shinomiya, Taku Oikawa, Sohsuke Yamada, Shiro Mizuno, Respiratory Medicine Case Reports, 38:101694-101694, Jun. 2022
Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancer, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Yuki Fujimoto, Taku Oikawa, Shiro Mizuno, Thorac Cancer, 13:624-630, Feb. 2022
Investigation of response of patients with non－small cell lung cancer to docetaxel（plus ramucirumab) therapy in second-line treatment, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, 14:3549-3555, Nov. 2023
A case of severe pneumonia caused by Legionella longbeachae with positive results by a Legionella urinary antigen detection kit, ShoheiShinomiya, Takuya Tanaka, Ikuyo Shionoya, Tatsuki Mura, Keisuke Nakase, Yutaka Takahara, Taku Oikawa, Shiro Mizuno, 10:1-5, Jun. 2023
Investigation of response factors for monotherapy with immnune checkpoint inhibitors in non-small cell lung cancer patients with PD-L1 expression <50%, Yutaka Takahara, Ryudai Abe, Nagae Sumito, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Takua Oikawa, 27:2754-2760, Sep. 2023
Influencing factors of efficacy and long-term use of amrubicin in patients with small cell lung cancer, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno, 14:1286-1293, May 2023
Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy, Yutaka Takahara, Ryudai Abe, Nagae Sumito Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Kazuaki Nishiki, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Thorac Cancer, 2024:1-7, Mar. 2024
Investigation of the Efficacy of Epidermal Growth Factor Receptor（EGFR）－Tyrosine Kinase Inhibitor in Patients With Exon 21 L858R Point Mutation-Positive Non-small Cell Lung Cancer, Yutaka Takahara, Ryudai Abe, Sumito Nagae, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Masafumi Nojiri, Masaharu Iguchi, Cureus, 16:e68411, Jun. 2024
Simultaneous Bilateral Spontaneous Pneumothorax complicated with Re-expansion Pulmonary Edema., Iwai S, Ishikawa M, Iijima Y, Motono N, Shionoya I, Ishige Y, Uramoto H., JOURNAL OF KANAZAWA MEDICAL UNIVERSITY, 49:94-97, Sep. 2024
